一种在异基因移植前降低供体特异性HLA抗体的策略。 - Suppr

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

作者信息

Gergis U, Mayer S, Gordon B, Mark T, Pearse R, Shore T, Van Besien K

机构信息

Division of Hematology and Medical Oncology, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY, USA.

出版信息

Bone Marrow Transplant. 2014 May;49(5):722-4. doi: 10.1038/bmt.2014.11. Epub 2014 Feb 17.

DOI:10.1038/bmt.2014.11

PMID:24535131

Abstract

摘要

相似文献

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

Bone Marrow Transplant. 2014 May;49(5):722-4. doi: 10.1038/bmt.2014.11. Epub 2014 Feb 17.

Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.

Transfusion. 2016 Jan;56(1):164-9. doi: 10.1111/trf.13263. Epub 2015 Aug 11.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

Stem Cells Transl Med. 2016 Apr;5(4):524-9. doi: 10.5966/sctm.2015-0196. Epub 2016 Feb 2.

Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant. 2015 Nov;21(11):1939-47. doi: 10.1016/j.bbmt.2015.06.014. Epub 2015 Jun 23.

Acute mixed-lineage leukemia treated with desensitization therapy prior to HLA-haploidentical transplantation with high donor-specific antibodies.

Int J Hematol. 2024 Aug;120(2):256-261. doi: 10.1007/s12185-024-03775-3. Epub 2024 Apr 27.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Biol Blood Marrow Transplant. 2011 May;17(5):640-8. doi: 10.1016/j.bbmt.2010.07.022. Epub 2010 Jul 30.

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.

Leukemia. 2015 Sep;29(9):1891-900. doi: 10.1038/leu.2015.98. Epub 2015 Apr 17.

[Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].

Rinsho Ketsueki. 2013 Feb;54(2):214-8.

[Human leukocyte antigen (HLA)-haploidentical hematopoietic stem cell transplantation for 8 patients with leukemia and review of the literature].

Zhonghua Zhong Liu Za Zhi. 2010 Aug;32(8):636-7.

引用本文的文献

Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-Fc fusion proteins.

Blood. 2022 Oct 20;140(16):1803-1815. doi: 10.1182/blood.2022016376.

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation.

Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):510-512. doi: 10.1016/j.htct.2021.11.019. Epub 2022 Jan 25.

Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.

J Clin Lab Anal. 2020 Jul;34(7):e23261. doi: 10.1002/jcla.23261. Epub 2020 Feb 28.

[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].

Zhonghua Xue Ye Xue Za Zhi. 2018 Mar 14;39(3):190-195. doi: 10.3760/cma.j.issn.0253-2727.2018.03.004.

HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):645-650. doi: 10.1182/asheducation-2017.1.645.

Cord blood chimerism and relapse after haplo-cord transplantation.

Leuk Lymphoma. 2017 Feb;58(2):288-297. doi: 10.1080/10428194.2016.1190970. Epub 2016 Jun 23.

Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1065-1072. doi: 10.1016/j.bbmt.2016.02.010. Epub 2016 Feb 19.

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.

Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption.

Bone Marrow Transplant. 2015 Apr;50(4):613-4. doi: 10.1038/bmt.2014.321. Epub 2015 Jan 26.

本文引用的文献

Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

Biol Blood Marrow Transplant. 2013 Apr;19(4):647-52. doi: 10.1016/j.bbmt.2013.01.016. Epub 2013 Jan 22.

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.

Exp Hematol. 2012 Oct;40(10):792-9. doi: 10.1016/j.exphem.2012.06.003. Epub 2012 Jun 12.

Durability of antibody removal following proteasome inhibitor-based therapy.

Transplantation. 2012 Mar 27;93(6):572-7. doi: 10.1097/TP.0b013e31824612df.

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.

Blood. 2011 Nov 24;118(22):5957-64. doi: 10.1182/blood-2011-06-362111. Epub 2011 Oct 3.

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Blood. 2011 Dec 15;118(25):6691-7. doi: 10.1182/blood-2011-05-355263. Epub 2011 Sep 22.

Anti-HLA antibodies in double umbilical cord blood transplantation.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1704-8. doi: 10.1016/j.bbmt.2011.04.013. Epub 2011 May 3.

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.

Transplantation. 2004 Feb 27;77(4):542-8. doi: 10.1097/01.tp.0000112934.12622.2b.

Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.

Thromb Haemost. 2002 Dec;88(6):898-9.

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

N Engl J Med. 1989 Jan 26;320(4):197-204. doi: 10.1056/NEJM198901263200401.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献